TB-500, 5mg

TB-500

TB-500 Peptide Initial Research

In 1964, Dr. Goldstein and his professor Abraham White conducted research that mainly focused on the thymus gland and its functionality. They isolated the small proteins secreted by the thymus gland, located below the breast bone and above the heart and discovered Thymosin. During the course of the study, it was suggested by the research team that thymus gland functioning may impact immune deficiency and hormone release.(1)

TB-500 Peptide and Acute Wounds

In 1999, a research study was conducted on wounded rat test models, who were introduced to TB-500. Four days after the presentation, it was reported by the researchers that the TB-500 peptide rats exhibited an apparent 41% increase in re-epithelialization than control rats presented with saline. Seven days after the study, the TB-500 wounds were reported to be contracted by at least 11% more than the saline wounds. Upon analysis, it was concluded that TB500 may possibly induce angiogenesis and collagen deposition, increasing the wound healing rate.

TB-500 Peptide and Chronic Wounds

Research studies were carried out on normal rats and mice, diabetic mice, aged mice, and steroid-influenced rats. All these animals were served full-thickness punch wounds, and introduced to the TB-500 peptide. It was reported that the TB-500 appeared to accelerate the wound-healing process in all test models, regardless of the stated pre-existing conditions. Furthermore, phase 2 clinical trials were conducted on test subjects with stasis and pressure ulcers. It was reported that TB-500 might accelerate the healing process by as much as one month.(2)

TB-500 Peptide and Heart Function

Pulmonary hypertension is considered by scientists to be a progressive cardio disease where the pulmonary arteries restrict the blood ejection by the right ventricle. This may result in increased pulmonary vascular resistance and pressure, potentially leading to ventricular failure of the heart. It was reported by reasearchers that TB-500 might be action specific on the Notch3-Col 3A-CTGF gene axis in MCT-influenced mice, which appeared to result in the case of the test study in decreasing the right ventricular hypertrophy by a significant amount.(3)

TB-500 and Hair Follicle Growth

In 2003, studies were carried out on mice to examine the potential of TB-500 in hair growth. Under the influence of the TB-500 peptide, it was reported by the researchers that, via histological examination of the mouse skin cells, the peptide appeared to increase the number of hair shafts and hair follicles, thereby inducing hair growth. Upon real-time PCR and western blotting techniques, changes in the expression of m-RNA cells were observed between the TB500 and control mice. The m-RNA and protein levels were reported elevated in TB-500 mice, which might have significantly induced hair growth.(4)

1. 1. Julia Parmley, A Life-Saving Discovery, January 04, 2010.
   2. Treadwell T, Kleinman HK, Crockford D, Hardy MA, Guarnera GT, Goldstein AL. The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients. Ann N Y Acad Sci. 2012 Oct.
   3. Wei C, Kim IK, Li L, Wu L, Gupta S. Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. PLoS One. 2014 Nov 20;9(11):e110598.
   4. Gao, Xy., Hou, F., Zhang, Zp. et al. Role of thymosin beta 4 in hair growth. Mol Genet Genomics 291, 1639–1646 (2016).
   5. A Phase 2 study of the effect of Thymosin Beta 4 on Wound Healing in Patients https://www.clinicaltrials.gov/ct2/show/NCT00311766